Biodel To Report Fourth Quarter Fiscal Year 2012 Financial Results On December 18, 2012

DANBURY, Conn., Dec. 14, 2012 (GLOBE NEWSWIRE) -- Biodel Inc. (Nasdaq:BIOD) will issue its fourth quarter fiscal year 2012 financial results on December 18, 2012. Following the release of the company's financial results, Biodel's senior management will host a conference call to discuss the results and provide an update on the company's progress.
December 18, 2012 schedule:
   
7:30 a.m. U.S. Eastern Time: Q4 fiscal year 2012 results will be distributed
   
7:45 a.m. U.S. Eastern Time: Conference call participants should dial:
  +1 ( 877 ) 303 - 8028 (United States) or
  +1 ( 760 ) 536 - 5167 (International)
   
8:00 a.m. U.S. Eastern Time: Conference call begins

Interested parties may access a live audio webcast of the conference call in the investor section of Biodel's website at  www.biodel.com . The audio webcast will be archived and available for replay through the website. Interested parties may also access an audio replay by dialing (855) 859-2056 (US) or (404) 537-3406 (International) and entering conference ID number 73281904.

About Biodel Inc.

Biodel Inc. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for diabetes that may be safer, more effective and more convenient for patients. We develop our product candidates by applying our proprietary formulation technologies to existing drugs in order to improve their therapeutic profiles.   

BIOD-G
CONTACT: Seth D. Lewis, +1-646-378-2952

If you liked this article you might like

3 Biotech Stocks Under $10 to Trade for Big Gains

3 Biotech Stocks Under $10 to Trade for Big Gains

5 Stocks Under $10 Set to Soar: Must-See Charts

5 Stocks Under $10 Set to Soar: Must-See Charts

4 Stocks Under $10 Making Big Moves Higher

4 Stocks Under $10 Making Big Moves Higher

3 Breakout Biotech Stocks Trading for Under $10

3 Breakout Biotech Stocks Trading for Under $10

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar